A Single-Dose Study to Assess the Efficacy of Albuterol SPIROMAX in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB).

Trial Profile

A Single-Dose Study to Assess the Efficacy of Albuterol SPIROMAX in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB).

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Sep 2015

At a glance

  • Drugs Salbutamol (Primary)
  • Indications Bronchoconstriction
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Sep 2015 Primary endpoint has been met. (Maximum Percentage Fall From Baseline in Forced Expiratory Volume in 1 Second (FEV1) up to 60 Minutes After the Exercise Challenge), as per an article published in the Respiratory Medicine
    • 08 Sep 2015 Results published in the Respiratory Medicine
    • 23 May 2015 Last checked against ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top